US Broker Ratings

Merck & Co., Inc. (MRK) Stock Analysis: Strong Buy Ratings and 10% Potential Upside

Merck & Co., Inc. (NYSE: MRK), a titan in the healthcare sector, continues to capture investor attention with its robust market position and promising growth trajectory...

BioNTech SE (BNTX) Investor Outlook: Analyzing 31.92% Potential Upside Amid Biotech Innovations

BioNTech SE (NASDAQ: BNTX), a pioneering force in the biotechnology sector, has captured investor attention with its innovative approaches to immunotherapy and infectious disease treatment. Headquartered..

IQVIA Holdings, Inc. (IQV) Stock Analysis: Investors Eye 12% Upside in Healthcare Giant

IQVIA Holdings, Inc. (NYSE: IQV), a prominent player in the Healthcare sector, specifically within the Diagnostics & Research industry, presents a compelling investment opportunity for those..

Viatris Inc. (VTRS) Stock Analysis: Uncovering the 13% Potential Upside Amidst Healthcare Challenges

In the dynamic world of healthcare, Viatris Inc. (VTRS) stands as a compelling entity, navigating a complex landscape with its extensive portfolio of prescription and generic..

UnitedHealth Group (UNH) Stock Analysis: Exploring a 19.74% Potential Upside

UnitedHealth Group Incorporated (NYSE: UNH), a leading healthcare company, stands as a formidable player in the healthcare plans industry. With a market capitalization of $301.21 billion,..

BeOne Medicines Ltd. (ONC) Stock Analysis: Robust Growth Potential with 41% Revenue Growth

BeOne Medicines Ltd. (ONC), a prominent player in the biotechnology sector, has captured the attention of investors with its impressive growth trajectory and innovative oncology treatments...

United Therapeutics Corporation (UTHR) Stock Analysis: Exploring a 9.99% Potential Upside in the Biotech Sector

United Therapeutics Corporation (NASDAQ: UTHR) presents a compelling opportunity for investors interested in the healthcare sector, specifically in the niche of specialty and generic drug manufacturing...

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Exploring a 13.28% Upside Potential in the Healthcare Sector

Smith & Nephew SNATS, Inc. (NYSE: SNN) stands as a beacon in the healthcare sector, specializing in the development and manufacturing of medical devices. With a..

Universal Health Services, Inc. (UHS) Stock Analysis: A Look at the Healthcare Giant’s Growth Potential and Market Position

Investors with an interest in the healthcare sector might find Universal Health Services, Inc. (NYSE: UHS) a compelling addition to their portfolios. With a market capitalization..

Ascendis Pharma A/S (ASND) Stock Analysis: A Biotech Marvel with 26% Upside Potential

Ascendis Pharma A/S (NASDAQ: ASND), a Denmark-based biopharmaceutical innovator, is making waves in the biotechnology sector with its promising growth trajectory and a substantial 26.17% potential..

Royalty Pharma plc (RPRX) Stock Analysis: 16% Upside Potential Captures Investor Interest

Royalty Pharma plc (NASDAQ: RPRX) sits at a unique intersection of finance and healthcare, offering investors a distinctive opportunity to engage with the biopharmaceutical sector. With..

Novartis AG (NVS) Stock Analysis: Strong ROE and Solid Dividend Yield Amidst Market Volatility

Novartis AG (NVS) stands as a formidable player in the global healthcare sector, with a market capitalization of $254.27 billion, making it one of the leading..

Becton, Dickinson and Company (BDX): Investor Outlook on a Healthcare Giant with a 4.38% Upside

Becton, Dickinson and Company (NYSE: BDX) stands as a colossus in the healthcare sector, specializing in medical instruments and supplies, with a sprawling portfolio that caters..

Haleon plc (HLN) Stock Analysis: Exploring a Potential 20% Upside for Investors in the Healthcare Sector

Haleon plc (HLN), a prominent player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry, captures the spotlight with an intriguing investment..

Qiagen N.V. (QGEN) Stock Analysis: A 14.59% Potential Upside in the Healthcare Sector

Qiagen N.V. (QGEN) is making waves in the healthcare sector with its innovative approach to diagnostics and research. Headquartered in Venlo, Netherlands, Qiagen specializes in providing..

Humana Inc. (HUM) Stock Analysis: Exploring a 21.65% Upside Potential Amidst Healthcare Growth

Humana Inc. (NYSE: HUM) stands as a formidable player in the healthcare plans industry, boasting a market capitalization of $28.52 billion. As a pivotal entity within..

McKesson Corporation (MCK) Stock Analysis: A Defensive Play with Growth Potential and a 10.36% Upside

McKesson Corporation (NYSE: MCK), a stalwart in the healthcare sector, is an intriguing proposition for investors seeking both stability and growth potential. With a market capitalization..

Alcon Inc. (ALC) Stock Analysis: Eyeing a 22.64% Upside in Healthcare Innovation

Alcon Inc. (NYSE: ALC), a prominent player in the medical instruments and supplies sector, is capturing investor attention with a robust market cap of $38.71 billion..

ICON plc (ICLR) Stock Analysis: Evaluating a 27% Upside Potential in the Healthcare Sector

Investors interested in the healthcare sector may find ICON plc (NASDAQ: ICLR) an intriguing prospect. This Dublin-based clinical research organization, with a market cap of $12.48..

Koninklijke Philips N.V. (PHG) Stock Analysis: Exploring the 17.98% Upside Potential

Koninklijke Philips N.V. (PHG), a stalwart in the healthcare sector, continues to draw investor attention with its promising upside potential of 17.98%. Operating as a health..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds